
Yuvezzi’s Health Canada submission leads this week’s recap, plus AI front desks, the EMERALD trial, and Alberta’s scope expansion.
Eric Donnenfeld, MD, discusses how to manage the moderate to severe dry eye disease patient at Twin Cities Ocular Surface Disease Symposium 2019.





